ArticleBMC infectious diseases2025
The role of TGF-β1 C-509T and TGF-β1 T869C polymorphisms in susceptibility to tuberculosis infection in a Sudanese population: a case-control study.
Article in BMC infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTuberculosis (TB) affects around 10 million people globally every year. The death rate from TB disease is substantial (almost 50%) if treatment is not received. In 2023, Sudan’s tuberculosis incidence is estimated at 134 cases per 100,000 population, with a 95% confidence interval of 125 to 145 cases per 100,000. The current tuberculosis mortality rate in Sudan is estimated at 25.0 deaths per 100,000 individuals. Several previous studies established an association between different cytokine genetic variants and TB across different ethnic groups. To our knowledge, no published studies have investigated the association between TGFβ1 polymorphisms (such as −509 C/T or T869C) and tuberculosis susceptibility in the Sudanese population.
methodA case-control study was conducted at Abu Anja Chest Hospital, Omdurman, Khartoum State, Sudan, between February 2018 and February 2021. A total of 200 EDTA blood samples were collected from patients newly diagnosed with pulmonary tuberculosis, and 200 EDTA blood samples from healthy controls. DNA extraction was done using the guanidine chloride method. Genotyping was performed using PCR-RFLP to investigate the influence of the TGF-β1 C-509T and TGF-β1 T869C polymorphisms on the susceptibility of Sudanese patients to pulmonary tuberculosis infection. Version 20.0 of IBM SPSS was used to analyze the data. (IBM Corp., Armonk, NY).
resultThe mutant and heterozygous genotypes in the TGF-β1-509 C/T polymorphism were associated with a nearly threefold increased risk of TB development in the Sudanese population (P-value < 0.001, OR 2.688, 95% CI 1.638–4.411). No statistically significant differences in genotype or allele frequencies of the TGF-β1 T869C gene were observed between patients and controls.
conclusionThe presence of even a single mutant allele (C) in this locus, 509T in TGFβ1, confers a significant risk of developing TB in Sudanese ethnics. CLINICAL TRIAL NUMBER: Not applicable. This article is extracted from my Ph.D. thesis entitled: The Role of Host Cytokine Genetic Polymorphism in Susceptibility to Mycobacterium Tuberculosis Infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.